Cargando…
Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
INTRODUCTION: Bladder cancer (BLCA) is the ninth most common malignancy worldwide and the fourth most common cancer in men. Copper levels are significantly altered in patients with thyroid, breast, lung, cervical, ovarian, pancreatic, oral, gastric, bladder, and prostate cancers. Outcomes can be pre...
Autores principales: | Shen, Junlin, Du, Mingyang, Liang, Shuang, Wang, Linhui, Bi, Jianbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442536/ https://www.ncbi.nlm.nih.gov/pubmed/37614950 http://dx.doi.org/10.3389/fmed.2023.1222543 |
Ejemplares similares
-
Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
por: Shen, Junlin, et al.
Publicado: (2023) -
Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023) -
Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022) -
Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
por: Li, Hanrong, et al.
Publicado: (2023) -
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)